Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
4,362.00    -472.00 (-9.76%)
Bid:
4,362.00
Ask:
4,368.00
Spread: 6.00 (0.138%)
Market Cap: $1.15t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Future Business Management Plan

29 Jun 2026 10:05

RNS Number : 1618K
Samsung Electronics Co. Ld
29 June 2026
 

Future BusinessManagement Plan (fair disclosure)

 

 

※ The following information contains forward-looking statements and is subject to change.

1. Future business plan

 Domestic investment vision for 2026-2040

 

 

2. Major details and implementation schedule

Purpose

To strengthen the competitiveness of the Company's core businesses

Details

Investment in the global cutting-edge semiconductor business, etc.

Implementation schedule

Start date

January 1, 2026

End date

December 31, 2040

Expected investment amount

Approximately KRW 2,450 trillion (including approximately KRW 2,100 trillion for the semiconductor business) . KRW 1,650 trillion for the Yongin semiconductor cluster and existing semiconductor complexes / KRW 400 trillion for Gwangju / DX, Display and other businesses . Construction of an HBM Fab in Onyang, Cheonan . Development of a global advanced semiconductor cluster in Gwangju . Construction of a humanoid robot production line in Gumi

Expected effects

Strengthened competitiveness of the Company's core businesses

3. Risk factors

 -

4. Date of Board resolution (Decision date)

 -

 

5. Information disclosure

Disclosing department

IR team

Recipients

Domestic and international investors, the media, etc.

Scheduled disclosure date and time

June 29, 2026, 5:10 p.m. (KST)

Event (venue)

National Briefing on the Three Mega Projects for Korea's Grand Leap Forward (The Presidential Office)

6. Contact information (Related department/Telephone Number)

IR team (02-2255-9000)

7. Other information material to investment decisions

The above mid- to long-term investment plan is provided as a guideline for reference based on the current market conditions. It is subject to change depending on future market conditions and changes in the Company's business environment.

Scheduled date of progress disclosure

Related disclosure

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLMLTMTMTMBF
Date   Source Headline
6th Jul 20187:00 amRNS2Q 2018 Pre-Earnings Guidance
4th Jun 20189:08 amRNSRecord Date for Proposed Dividends
4th Jun 20188:57 amRNSRecord Date for Proposed Dividends
4th Jun 20188:53 amRNSCorporate Governance Report 2018
30th May 20189:33 amRNSAnnouncement of Investor Relations Event
30th May 20188:54 amRNS2018 1Q Interim Report
30th Apr 20188:59 amRNS2017 Business Report
27th Apr 20188:46 amRNSCharitable Contribution
26th Apr 20189:40 amRNSTransaction with Affiliate Company
26th Apr 20189:27 amRNSPurchase of Assets
26th Apr 20189:22 amRNSTransaction with Affiliate Company
26th Apr 20187:00 amRNSQuarterly Dividend for First Quarter 2018
26th Apr 20187:00 amRNS2018 1Q Earnings Release
20th Apr 20187:39 amRNSUpdate on Stock Split
6th Apr 20187:00 amRNS1Q 2018 Pre-Earnings Guidance
6th Apr 20187:00 amRNSTransaction with Affiliate Company
6th Apr 20187:00 amRNSNotice of 1Q 2018 Earnings Release Schedule
23rd Mar 20187:32 amRNSCharitable Contribution
23rd Mar 20187:25 amRNSTransaction with Affiliate Company
23rd Mar 20187:23 amRNSResults of the 49th Annual General Meeting
23rd Mar 20187:13 amRNSAppointment of New Representative Directors
16th Mar 20187:10 amRNSDecision on Stock Split(Update)
14th Mar 20187:00 amRNSRecord Date for Proposed Dividends
28th Feb 20187:44 amRNS2017 Consolidated Financial Statements
23rd Feb 20189:03 amRNSCharitable Contribution
23rd Feb 20189:02 amRNSReference Material for 2018 AGM
6th Feb 20189:50 amRNSTrial Court Judgment relating to Embezzlement
31st Jan 20187:54 amRNSDecision on Stock Split
31st Jan 20187:43 amRNSCharitable Contribution
31st Jan 20187:25 amRNSTransaction with Affiliate Company
31st Jan 20187:00 amRNSYear-End Cash Dividend for FY2017
31st Jan 20187:00 amRNS2017 4Q Earnings Release
30th Jan 20188:32 amRNSResults of Share Repurchase Program
29th Jan 20188:46 amRNSTrial Court Judgment relating to Embezzlement
9th Jan 20187:51 amRNSNotice of 4Q 2017 Earnings Release Schedule
9th Jan 20187:00 amRNS4Q 2017 Pre-Earnings Guidance
29th Dec 20177:00 amRNSCorporate Governance Report 2017
15th Dec 20177:02 amRNSAnnouncement of Record Date for AGM
29th Nov 20177:22 amRNS2017 3Q Interim Report
24th Nov 20177:10 amRNSTransaction with Affiliate Company
24th Nov 20177:06 amRNSCharitable Contribution
2nd Nov 20177:00 amRNSSale of Business Operations (Update)
31st Oct 20177:00 amRNSAnnouncement of CAPEX Plan for FY 2017
31st Oct 20177:00 amRNSApproval of Share Repurchase and Cancellation Plan
31st Oct 20177:00 amRNSShareholder Return Program for FY2018-2020
31st Oct 20177:00 amRNSQuarterly Dividend for Third Quarter 2017
31st Oct 20177:00 amRNS2017 3Q Earnings Release
13th Oct 20178:06 amRNSNotice of 2017 Q3 Earnings Release Schedule
13th Oct 20177:00 amRNS2017 3Q Pre-Earnings Guidance
22nd Sep 20178:09 amRNSNotice of 2017 Q3 Pre-Earnings Guidance Schedule

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.